Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
Holding BDTX?
Track your performance easily

Black Diamond Therapeutics (BDTX) Ownership - Who Owns Black Diamond Therapeutics?

851 Followers

Black Diamond Therapeutics (BDTX) Ownership Overview

19.45%17.23%1.20%7.36%54.77%
19.45% Insiders
1.20% Other Institutional Investors
7.36% ETFs
54.77% Public Companies and Individual Investors
The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 25.79% of the company’s stock is owned by Institutional Investors, 19.45% is owned by Insiders, and 54.77% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 30, 2024
xxxxxxxxxxxxx
$1400512

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,206,964Insider10.97%20,420,912
4,506,341Insider7.96%14,825,862
3,525,754Institution6.23%11,599,731
2,588,023Institution4.57%8,514,596
2,469,234Institution4.36%8,123,780
2,219,835Institution3.92%7,303,257
1,807,139Institution3.19%5,945,487
1,558,733Institution2.75%5,128,232
1,199,658Institution2.12%3,946,875
605,901Institution1.07%1,993,414

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,588,023Institution4.57%8,514,596
2,469,234Institution4.36%8,123,780
1,807,139Institution3.19%5,945,487
1,199,658Institution2.12%3,946,875
396,911Institution0.70%1,305,837
373,922Institution0.66%1,230,203
184,394Institution0.33%606,656
165,800Institution0.29%545,482
105,812Institution0.19%348,121
102,203Institution0.18%336,248

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,329,831Institution2.35%5,784,765
1,088,474Institution1.92%3,581,079
600,308Institution1.06%2,611,340
253,432Institution0.45%833,791
182,162Institution0.32%792,405
118,125Institution0.21%388,631
119,086Institution0.21%378,693
90,363Institution0.16%297,294
84,702Institution0.15%269,352
71,018Institution0.13%233,649

FAQ

Who Owns Black Diamond Therapeutics (BDTX)?
According to the latest TipRanks data, approximately 1.20% of the company's stock is held by institutional investors, 19.45% is held by insiders, and 54.77% is held by retail investors.
    What percentage of Black Diamond Therapeutics (BDTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.20% of Black Diamond Therapeutics (BDTX) stock is held by institutional investors.
      What percentage of Black Diamond Therapeutics (BDTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.77% of Black Diamond Therapeutics (BDTX) stock is held by retail investors.
        Who owns the most shares of Black Diamond Therapeutics (BDTX)?
        Versant Venture Capital VI, L.P. owns the most shares of Black Diamond Therapeutics (BDTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis